Published October 2019 | Version v1
Journal article

Radiation Therapy Without Hormone Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation

  • 1. Levine Cancer Institute, Atrium Health, Charlotte, North Carolina (United States)
  • 2. 21st Century Oncology, Farmington Hills (United States)
  • 3. Ichan School of Medicine at Mt. Sinai, New York City, New York (United States)
  • 4. University of Michigan, Ann Arbor (United States)
  • 5. Beth Israel Deaconess Medical Center, Boston (United States)
  • 6. Arizona Oncology, Tucson (United States)
  • 7. Memorial Sloan Kettering Cancer Center, New York City, New York (United States)
  • 8. Cancer HealthCare Associates, Miami (United States)
  • 9. Taussig Cancer Institute, Cleveland Clinic, Cleveland (United States)

Description

Hormone therapy without radiation therapy is considered appropriate for women age 70 or above with low-risk, hormone-positive breast cancer after partial mastectomy. However, some patients may prefer radiation without hormone therapy, for which there is minimal modern data. We modeled the comparative efficacy of aromatase inhibition alone without radiation versus radiation alone without hormone therapy.

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2019.06.014;
PII
S0360301619308491;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
105
Journal Issue
2
Journal Page Range
p. 296-306
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
55057333
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
HEALTH HAZARDS; HORMONES; INHIBITION; MAMMARY GLANDS; NEOPLASMS; PATIENTS; RADIOTHERAPY; WOMEN
Descriptors DEC
ANIMALS; BODY; DISEASES; FEMALES; GLANDS; HAZARDS; HUMANS; MAMMALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PRIMATES; RADIOLOGY; THERAPY; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2019 Elsevier Inc. All rights reserved.